Company Data
StageZero Life Sciences Ltd
Ticker
SZLSF
Current Price
$0.0005
Market Cap
$61.8K
Price Target
Refer to Report
52wk Range
$0.0005 - $0.0727
Overview
StageZero Life Sciences Ltd is a Canadian company, focused on developing and commercializing proprietary molecular diagnostic tests for early detection of diseases and personalized health management, with a primary focus on cancer-related indications. It develops a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. Its lead product, ColonSentry is a blood test to determine the patient’s current risk of having colorectal cancer.